| 000 | 01411 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518015052.0 | ||
| 264 | 0 | _c20200113 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1471-2288 | ||
| 024 | 7 |
_a10.1186/s12874-018-0650-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Ravenhorst, Mariëtte B | |
| 245 | 0 | 0 |
_aUse of saliva to monitor meningococcal vaccine responses: proposing a threshold in saliva as surrogate of protection. _h[electronic resource] |
| 260 |
_bBMC medical research methodology _c01 2019 |
||
| 300 |
_a1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xanalysis |
| 650 | 0 | 4 |
_aBacterial Capsules _ximmunology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xanalysis |
| 650 | 0 | 4 |
_aMeningitis, Meningococcal _xprevention & control |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _ximmunology |
| 650 | 0 | 4 |
_aNeisseria meningitidis, Serogroup C _ximmunology |
| 650 | 0 | 4 |
_aSaliva _ximmunology |
| 650 | 0 | 4 | _aVaccination |
| 700 | 1 | _avan der Klis, Fiona R M | |
| 700 | 1 | _avan Rooijen, Debbie M | |
| 700 | 1 | _aSanders, Elisabeth A M | |
| 700 | 1 | _aBerbers, Guy A M | |
| 773 | 0 |
_tBMC medical research methodology _gvol. 19 _gno. 1 _gp. 1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12874-018-0650-3 _zAvailable from publisher's website |
| 999 |
_c29222798 _d29222798 |
||